Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized patients with CAP.
Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.
People who work against their internal clock over a long period of time increase the risk of fatty liver. The correlations ...
A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback